Established in the August 2024;Officially opened on November 11, 2024;The First trial will be launched in December 2024;
“守护患者生活健康”
“提升患者生存质量”
“满足患者用药需求”
“以患者为中心”
“积极拥抱变化”
“坚持自主创新，创造世界品牌”
“成为一家持续创造价值的百年药企”
“创新驱动”
“治愈疾病
